Credits: Health and me
The debate over what causes autism has reignited once again. A forthcoming report from the U.S. Department of Health and Human Services, led by Secretary Robert F. Kennedy Jr., is expected to link prenatal use of acetaminophen (Tylenol) and vitamin deficiencies to autism spectrum disorder (ASD). The report is already drawing sharp criticism from scientists who say the claims lack solid evidence and risk fueling confusion among parents.
At the same time, the Centers for Disease Control and Prevention (CDC) has released its latest data on autism prevalence, reflecting more than two decades of careful monitoring. Together, these two developments highlight the tension between scientific evidence and political narratives—and underscore the urgent need to separate facts from speculation.
Acetaminophen, widely sold under the brand name Tylenol, is one of the most commonly used painkillers in the United States, including during pregnancy. The new report, according to The Wall Street Journal, is expected to suggest that prenatal Tylenol exposure, combined with low folate levels, may increase autism risk. It will also highlight folinic acid (leucovorin), a form of vitamin B9, as a potential therapy for easing autism symptoms.
However, major medical organizations strongly disagree. The Society for Maternal-Fetal Medicine stated that acetaminophen is both safe and necessary during pregnancy, especially for managing fever and pain. Untreated fever in early pregnancy, the group noted, is linked to miscarriage, premature birth, and birth defects, while untreated pain can lead to maternal depression, anxiety, and hypertension.
Drugmaker Kenvue, which markets Tylenol, also emphasized that decades of safety evaluations show no proven causal link between acetaminophen and autism. “We have continuously evaluated the science and continue to believe there is no causal link,” the company said.
A few small observational studies have hinted at possible associations between acetaminophen use in pregnancy and later diagnoses of autism or ADHD. But association is not causation, and those studies lacked the statistical power to draw strong conclusions.
The largest and most comprehensive research on the subject, an NIH-funded collaboration between U.S. and Swedish scientists, found no increased risk of autism from prenatal acetaminophen exposure. Similarly, a U.S. District Court dismissed product liability claims linking Tylenol to autism, concluding the science was insufficient to support such allegations.
“Claims like these can spread unnecessary fear among expectant mothers,” said experts from the Autism Science Foundation, which has called for caution. The organization noted that while early research suggests folate levels during pregnancy may play a role in autism risk, the evidence is still preliminary.
Folate, a B vitamin critical for brain and spinal development, has long been a cornerstone of prenatal care. Women are routinely advised to take folic acid supplements to prevent neural tube defects such as spina bifida.
The upcoming HHS report suggests that folinic acid (leucovorin), a specific form of folate, could reduce autism symptoms in some children. This idea is based on research showing that some people with autism may have metabolic differences that limit folate transport to the brain. Leucovorin appears to bypass that barrier.
Still, the scientific community remains cautious. The Autism Science Foundation points out that only four small studies have linked low maternal folate to higher autism risk, and evidence that leucovorin can treat autism is scant. “More research is needed before these findings can be considered clinically meaningful,” the group said.
While political battles unfold, the CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network provides a clearer, evidence-based picture of autism in America. Since 2000, the CDC has tracked prevalence among 8-year-olds, offering the most comprehensive long-term data available.
In April 2024, the CDC reported that 1 in 31 U.S. children had autism by age 8—up from 1 in 150 in the year 2000. Boys remain far more likely to be diagnosed than girls, at a ratio of 3.5 to 1. Here’s how the numbers have shifted:
These numbers suggest not only a rise in autism prevalence but also improvements in diagnosis and awareness. Experts caution that higher rates don’t necessarily mean autism itself is more common but that detection has improved, especially among girls and children of color who were historically underdiagnosed.
Compared to other pediatric conditions, autism is far more prevalent than childhood cancer, which affects about 1 in 285 children before age 20. However, autism remains less common than chronic pediatric diseases like asthma, diabetes, or obesity, which impact nearly 30% of U.S. children.
What makes autism unique is that it is not a disease with a single cause or cure but a neurodevelopmental condition shaped by complex interactions of genetics, environment, and biology. Most experts agree there is no single “cause” of autism—contrary to RFK Jr.’s promise to “get to the bottom” of it.
Health experts warn that when public officials spotlight controversial or unproven theories, they risk undermining trust in established medical guidance. For pregnant women, the danger is clear- avoiding safe, recommended treatments like acetaminophen or folate supplements could put both mother and baby at risk.
Dr. Sarah Lister, a maternal-fetal medicine specialist not involved in the HHS report, summarized the concern: “We should be empowering women with facts, not fear. Linking autism to Tylenol without strong evidence can harm maternal health more than it helps.”
As the debate over Tylenol, folate, and autism unfolds, one fact stands unchallenged: autism diagnoses are rising, and the US now has a quarter century of data to prove it. But science points away from simple answers. Autism is a complex condition with many contributing factors—none of which can be reduced to a single pill or vitamin.
The challenge going forward is not just understanding autism but ensuring that families receive evidence-based care, free from politics and misinformation.
Credits: Canva
Canada’s leading drug regulator is facing a growing wave of concern over the popular diabetes and weight-loss medication Ozempic, after thousands of reports of adverse effects, some of them being severe, were recorded nationwide.
Health Canada confirmed it has received 11,707 individual reports of adverse reactions linked to drugs containing semaglutide, including Ozempic, Rybelsus, and Wegovy, since their introduction to the Canadian market seven years ago.
The agency has collected 2,706 separate reports detailing these side effects, about half coming from health professionals and half from patients, according to data obtained by Le Journal de Montréal.
The reported issues range from relatively mild gastrointestinal discomfort to severe events such as poisoning, vision loss, and psychiatric disorders. Gastrointestinal complaints alone account for one-third of the reports — highlighting how common nausea, vomiting, and constipation are among users.
For patients like Liliana Mejia, the experience was devastating.
“It was horrible,” she told Le Journal. “Everything made me want to vomit, my vision was blurred, [I was] tired and constipated for 10 days.”
She stopped using the drug after a little over a year but says she wishes she had been warned about the potential impact earlier. “I don’t think we talk about it enough,” Mejia added.
Her story mirrors that of many Canadians now speaking out about their struggles.
Ozempic was originally designed as a treatment for type 2 diabetes but has skyrocketed in popularity due to its ability to suppress appetite, leading to rapid weight loss.
“It’s a powerful and effective drug that has many benefits, but also side effects that need to be managed,” explained Dr. Rémi Rabasa-Lhoret, endocrinologist and researcher, in comments to Le Journal.
He emphasized that the reports do not necessarily prove a direct cause-and-effect relationship between Ozempic and the complications, but said that listening to patients is crucial. “It requires proper medical monitoring,” he noted, stressing that it should not be used casually or without supervision.
Among the most worrying findings are the psychiatric problems reported by patients, 470 cases have been logged so far. Dr. Rabasa-Lhoret said he has seen patients spiral into eating disorders such as anorexia due to overuse of the drug.
He also pointed to the unprecedented demand for Ozempic, comparing the craze to the hype around Viagra when it first launched. “Many people have started prescribing it without providing proper support to patients,” he lamented, adding that the rise of online pharmacies has made it dangerously easy to obtain the drug without adequate oversight.
One of the most troubling side effects being investigated is non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition that can lead to permanent vision loss.
Jacques Pépin, 69, of Repentigny, Quebec, believes Ozempic played a role in the two strokes he suffered in his eyes over the past year.
“I wouldn’t have taken it if I had known,” Pépin told Le Journal.
He has now lost much of his sight and says he can no longer drive, read, or enjoy his favorite hobby — building model airplanes. “I break glasses, I have no balance,” he said, describing how the vision loss has upended his life.
Health Canada has logged 10 cases of NAION and is currently “reviewing relevant preliminary information on the potential risk.” Novo Nordisk, the drug’s manufacturer, denies a causal link, though its European labels are being updated to include NAION as a potential adverse reaction.
Despite the concerning data, experts caution against panic. Sherbrooke endocrinologist Dr. André Carpentier told Le Journal that while the list of side effects can seem alarming, the drug’s benefits, from controlling diabetes to protecting heart and kidney health, are significant and must be weighed carefully against the risks.
“The link with Ozempic is difficult to establish beyond doubt,” Dr. Carpentier said, noting that certain complications, like sudden drops in blood sugar, can themselves trigger issues like vision problems.
Health Canada continues to collect and analyze data, and experts stress that the key is proper prescription, patient education, and close monitoring. For patients like Mejia and Pépin, however, the damage is already done, and their stories are sparking calls for more transparency about what users can expect before starting these medications.
Credits: Canva
Every year on 10th of September the world observes World Suicide Prevention Day. The day is organized by the International Association for Suicide Prevention (IASP) to raise awareness around the globe that suicide can be prevented.
As per the World Health Organization (WHO), more than 720,000 people die due to suicide every year and it is the third-leading cause of death among 15-29-year-olds. The WHO also provides that 73% of the global suicides occur in low-and-middle-income countries. The reasons are influenced by social, cultural, biological, psychological, and environmental factors present. As per the World Population Review's 2021 report the five countries with highest suicide rates are:
The triennial theme for 2024-2026, "Changing the Narrative on Suicide", with the call to action "Start the Conversation", reflects a significant shift in how society approaches suicide. Historically, suicide has been shrouded in silence, stigma, and fear. The goal now is to transform this narrative by encouraging open, honest discussions about mental health, suicide prevention, and the factors that contribute to suicidal thoughts and behaviors.
Starting conversations, whether at home, in schools, or workplaces, we can create a supportive culture that reduces the stigma attached to mental health. Changing the narrative is also about advocating for policies that prioritize mental health, increasing access to care, and ensuring that support systems are in place for those in need. This year's theme underscores that everyone, regardless of their role, can contribute to preventing suicides simply by being willing to listen and engage in meaningful discussions.
In recent years, the conversation surrounding suicide has expanded to include a wide array of contributing factors. Issues such as relationship troubles, financial difficulties, business failures, mental health disorders, substance abuse, and health problems are frequently associated with suicidal behaviors. However, an alarming trend has emerged: an increase in suicidal thoughts among school-aged children.
The pressures placed on children, especially in academic environments, are often a significant source of mental stress. As societal expectations on performance grow, children are left grappling with overwhelming anxiety, fear of failure, and a lack of emotional outlets to express their struggles. Suicide prevention efforts must focus on this vulnerable group, ensuring they receive the emotional and psychological support they need to cope with life’s challenges.
Established in 2003 by the ASP in collaboration with the WHO, World Suicide Prevention Day seeks to raise global awareness around suicide and its prevention. This annual event provides a platform to discuss strategies to reduce suicide rates, challenge misconceptions, and advocate for better mental health care.
The day’s significance lies in its mission to mobilize governments, communities, and individuals to confront the often-taboo subject of suicide. By bringing suicide prevention into public discourse, the aim is to foster a more understanding and supportive society, where mental health challenges are treated with the same urgency as physical illnesses. With each passing year, World Suicide Prevention Day serves as a call to action to break down the barriers that prevent people from seeking help when they need it most.
Parents play a crucial role in suicide prevention, particularly when it comes to safeguarding the mental health of their children. Creating an open and communicative home environment where children feel comfortable expressing their emotions is essential. Harsh criticism or unrealistic academic expectations can exacerbate mental health struggles, making it imperative for parents to approach setbacks with empathy and encouragement.
Parents should also monitor their child’s daily routines, such as their diet, sleep patterns, and study habits, as these can significantly impact their emotional well-being. By ensuring a balanced and supportive lifestyle, parents can help mitigate the risks of suicidal thoughts.
Communities and educators also have a responsibility in preventing suicides. Schools should implement programs that teach children about emotional intelligence, stress management, and coping mechanisms for failure. Involving mental health professionals in schools to provide guidance and support can be a critical step in early intervention.
Changing the narrative on suicide also requires systemic change, particularly in how mental health is addressed by policymakers. Governments must prioritize mental health in their agendas, ensuring that comprehensive mental health services are accessible to all, regardless of socioeconomic status. Suicide prevention policies should focus on improving access to mental health care, increasing funding for suicide prevention programs, and supporting research on mental health issues.
Policymakers should also focus on improving mental health education, both in schools and workplaces, to foster environments where individuals feel comfortable seeking help. Suicide prevention is not just an individual responsibility but a societal one, where all stakeholders, from governments to local communities, must work together to save lives.
Credits: Health and me
An independent investigation has exposed a disturbing chapter in Greenlandic history, revealing that more than 350 Indigenous women and girls were forcibly given contraception by Danish authorities between the 1960s and mid-1970s. Some victims were as young as 12 years old. These findings highlight a legacy of systemic discrimination, control, and violations of human rights with far-reaching physical and psychological consequences.
The investigation revealed that the victims were either fitted with intrauterine devices (IUDs) or administered hormonal birth control shots without sufficient information or consent. The survivors reported agonizing side effects such as infections, bleeding, and long-term trauma.
Although the investigation concentrated on 354 women, Danish authorities estimate that over 4,000 women—approximately half of Greenlandic women of reproductive age at the time—were involved. The operations were performed under cover of public health policy, designed to restrict population growth as better healthcare and living standards produced a corresponding surge in births.
Nearly 150 Inuit women filed lawsuits against Denmark last year, claiming violations of human rights, with compensation claims still ongoing.
The forced contraception program was part of broader Danish policies that dehumanized Greenlandic Indigenous populations. These policies included removing Inuit children from their parents for re-education in Danish foster homes and the controversial parenting competency test, known as the FKU.
Greenland was a Danish province in 1953, became home-ruled in 1979, and gained self-government in 2009. Though political development was made, the effects of such interventions persist among families and communities. Contraception and biased measurements such as the FKU were instruments of authority that disregarded Greenlandic culture and contravened international human rights conventions.
The FKU, or the forældrekompetenceundersøgelse, was a psychometric test aimed at determining if parents were fit to raise their children. Even though the test was meant to safeguard the children, it disproportionately affected the Greenlandic families.
Global human rights agencies, such as the Danish Institute for Human Rights and the UN Special Rapporteur on the Rights of Indigenous Peoples, condemned the test on grounds of cultural insensitivity. They stated that the FKU contravened Denmark's obligations under conventions such as ILO Convention No. 169, which binds states to uphold Indigenous cultural identity.
The test was formally dropped in January 2025 following decades of lobbying by human rights organizations, Greenlandic governments, and Indigenous lobby groups.
The research gathered testimonies from 48 to 89-year-old women during the time of interviews. The majority of victims ranged between 12 and 37 years old when they were forcedly contracepted. A single girl was below 12 years, although her identity was not disclosed to ensure her privacy.
The victims also experienced physical and psychological trauma, such as chronic pain and infections, to helplessness and shame. The practices, conducted without informed consent, are deemed a blatant disregard for human rights.
In a bid to clear the scandal before the report was published, Denmark and Greenland governments jointly apologized last month. Children's Minister of Greenland Dr. Aqqaluaq B. Egede termed the apology as a "late but necessary measure," highlighting the need to stop further damage.
There is an official apology ceremony planned for September 24 in Nuuk, Greenland, and the purpose of which is to recognize wrongs of the past and to start a road towards reparation.
The trauma of forced contraception and discriminatory parenting tests has left a lasting impact on Greenlandic women's mental health across generations. Survivors indicate high levels of anxiety, depression, and post-traumatic stress, frequently associated with shame, loss of autonomy, and betrayal by state institutions. Body image disturbance and reproductive anxieties were widespread, with many women fearing future pregnancy or medical procedures.
The psychological weight is felt beyond the direct victims. Families and communities have cited intergenerational trauma, with the younger generations learning mistrust of healthcare professionals and government institutions. Mental health practitioners in Greenland have pointed out that decades of systematic abuses have led to chronic stress, loneliness, and inability to develop secure family attachments.
Dr. Aqqaluaq recognized the deep psychological effects, saying, "The damage inflicted was not just physical—it has left deep emotional wounds that last for decades. It requires long-term mental health care, culturally appropriate counseling, and recognition of historical injustices.
It is argued by experts that mental health programs need to integrate trauma-informed care specific to the cultural and social environment of Greenlandic Indigenous women. It is only through ongoing support and acknowledgment of these past injustices that communities can start healing from the lasting effects of forced contraception and discriminatory parental evaluations.
For Greenland, this inquiry is a step in the direction of recognizing past injustices, maintaining Indigenous rights, and guaranteeing no future generations of Greenlanders will experience similar abuses. It also draws attention to the urgent need for worldwide consciousness of reproductive justice, cultural awareness, and long-term implications of human rights violations.
© 2024 Bennett, Coleman & Company Limited